Followers | 78 |
Posts | 7034 |
Boards Moderated | 0 |
Alias Born | 03/19/2009 |
Wednesday, July 12, 2017 8:34:11 AM
At the In-Process Review meeting on February 2, 2017, AMCG/BARDA provided the decision-making body with the wrong slides for the meeting. Aeolus was forced to present its case for option exercise with a presentation that did not contain critical, up-to-date information on the program's status and accomplishments.
Has nothing to do with AEOL 10150. They have teamed up for many years to develop the drug and I'm confident we get the approval for Lung-ARS treatment. Just my opinion though
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM